608 Tivozanib biomarker identifies tumor infiltrating myeloid cells contributing to tivozanib resistance in both preclinical models and human renal cell carcinoma
2010 ◽
Vol 8
(7)
◽
pp. 191
◽
Keyword(s):
Keyword(s):
Keyword(s):
1988 ◽
Vol 263
(28)
◽
pp. 14107-14114
Keyword(s):
2017 ◽
Vol 10
(2)
◽
pp. 142-152
◽
2000 ◽
Vol 7
(1)
◽
pp. 16-21
◽
Keyword(s):
1998 ◽
Vol 41
(9)
◽
pp. 1507-1512
◽